# V3 Replay AIC Top 20 — Stimulation / Synthesis Record

Date: 2026-08-15
Source experiment: V3 Replay AIC candidate materialization
Replay root: `4d10e01c5c246133`

## Execution status

**Mode:** ENGINE-SUBSTRATE STIMULATION / SYNTHESIS

The repository currently contains the A2 synthesis/evidence/adversarial pipeline, while the linked Technology Evolution Engine contains mechanism-transfer, hypothesis, prediction, adversarial-analysis, and experiment-design components. The current engine status explicitly states that invention synthesis is not implemented and that simulation is not yet an authorized active-path capability. Therefore this record does **not** claim that a separate production "stimulation engine" was executed. It records a disciplined synthesis using the implemented reasoning contracts, followed by an external prior-art sanity check.

## Top 20 seed candidates

The 20 seeds were selected for mechanism depth, architectural leverage, transfer distance, specificity, and distinctiveness rather than raw AIC count. Shared duplicates were represented once where possible.

| # | Arm | Problem | Seed |
|---:|---|---|---|
| 1 | M4B | fd_059 | Marker-free / differentiable-rendering surgical-robot pose estimation |
| 2 | M4B | fd_039 | Nanozyme ROS-scavenging layer for CGM interface |
| 3 | M4B | fd_077 | Chain-entanglement / topological hydrogel interface |
| 4 | M4B | fd_049 | Multimode waveguide ultrasound architecture |
| 5 | M4B | fd_100 | Metallized-polymer / conductor architecture for CRT lead |
| 6 | M3 | fd_048 | Hybrid MRI gradient-coil thermal architecture |
| 7 | M0 | fd_060 | Pulsed RF energy delivery with real-time thermal-spread control |
| 8 | M0 | fd_056 | Real-time surgical staple-line compression feedback |
| 9 | M0 | fd_097 | Predictive implantable-defibrillator battery degradation forecasting |
| 10 | M2 | fd_097 | Real-time ICD battery-impedance degradation monitoring |
| 11 | M0 | fd_093 | Zr-MOF hemodialysis membrane architecture |
| 12 | M2 | fd_075 | Polymerizable QAM antimicrobial bone-cement chemistry |
| 13 | M0 | fd_044 | AI / reference-driven POCUS self-calibration |
| 14 | M4 | fd_049 | Self-healing polymer ultrasound transducer surface |
| 15 | M0/M2/M3/M4/M4B/M4C | fd_066 | Triboelectric energy harvesting for wearable medical sensing |
| 16 | M4B | fd_019 | Electrically controlled negative-surface heart-valve interface |
| 17 | M4 | fd_043 | Hydrogel-degradation state detection for ECG sensing |
| 18 | M4C | fd_044 | Post-acquisition POCUS calibration verification |
| 19 | M0/M4B | fd_041 | Wavelength-weighted / reference-assisted optical sensing |
| 20 | M4B | fd_070 | Secondary low-perfusion / NIR optical sensing architecture |

## Stimulation convergence

The strongest non-derivative convergence was not "add another sensor." It was:

**measure a physical state transition in a deliberately engineered reference element that experiences a known fraction of the same energy/environment as the therapeutic target, then use that reference transition to normalize the target-state estimate before closed-loop control.**

This convergence combines the following seed families without simply concatenating their devices:

- fd_060: closed-loop energy delivery + thermal state feedback
- fd_043: impedance/state sensing
- fd_044: self-calibration
- fd_054 / fd_041: internal optical/reference-channel calibration
- fd_077 / fd_078: engineered hydrogel state-transition interfaces
- fd_059: geometry/state estimation discipline
- fd_049: robust/self-healing sensor interface concept

## Generated invention candidate

**Working title:** State-Transition Reference Calibrator for Closed-Loop Electrosurgical Energy Control

**Core mechanism:** A physically co-located, electrically isolated reference micro-structure is designed to undergo a calibrated state transition as a function of delivered electrosurgical energy and local thermal exposure. The controller measures the reference transition and uses it as an internal dose/state reference to normalize tissue measurements before selecting the next RF pulse characteristics. The reference can be sensed through impedance, optical response, acoustic response, or a combination.

## Why this is materially different from the seed ideas

The novelty hypothesis is not "use impedance feedback," "use temperature sensing," or "use a hydrogel." Each of those appears in existing literature/patent art. The proposed center of gravity is the **co-located state-transition reference calibrator** and its use as an independent normalization signal for closed-loop therapeutic control.

## Adversarial pre-screen

1. **Prior-art risk — HIGH.** Closed-loop electrosurgical impedance control is old and extensively patented.
2. **Reference-sensor risk — HIGH.** Surgical systems with reference sensors are known.
3. **Thermosensitive-material risk — HIGH.** Temperature-sensitive gels/material layers used around electrosurgical electrodes are known.
4. **Thermal-dose-control risk — HIGH.** Real-time thermal-dose monitoring and closed-loop treatment control are established.
5. **Combination risk — HIGH.** A claim that merely combines these known elements would likely be weak.
6. **Potential differentiator — MEDIUM/HIGH.** A specifically co-located, electrically isolated state-transition reference element used as a calibrated fractional-field dosimeter to normalize target-state inference may provide a narrower novelty nucleus, but this is unverified.

## Falsifier

The invention candidate should be rejected as a novelty lead if a single earlier publication/patent is found that teaches the same combination of:

1. a therapeutic electrosurgical energy source;
2. a co-located non-therapeutic reference element exposed to a calibrated fraction of the same treatment field;
3. an engineered state transition in that reference element serving as an internal dose/state reference;
4. target-tissue measurement normalization using that reference state; and
5. closed-loop adaptation of subsequent energy delivery using the normalized state estimate.

## Required validation experiments

**Experiment A — reference repeatability:** characterize the reference transition versus applied energy, temperature, humidity, contact geometry, and manufacturing variation.

**Experiment B — normalization gain:** compare tissue-state estimation using raw tissue impedance/temperature against the same measurements normalized by the reference transition.

**Experiment C — control benefit:** compare fixed-energy, impedance-only, and reference-normalized closed-loop control in ex-vivo tissue.

**Experiment D — boundary stress:** vary tissue type, thickness, hydration, electrode pressure, contact angle, and sensor aging. The candidate fails if normalization does not reduce state-estimation error across these boundary conditions.

## Epistemic state

`INVENTION_CANDIDATE` — **unvalidated**

Not claimed to be novel, patentable, clinically safe, or commercially viable. A formal patentability opinion requires a professional patent search and legal analysis.
